Sequential Analysis of Neutrophil-To-Lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib

In Vivo - Greece
doi 10.21873/invivo.11828
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Anticancer Research USA Inc.

Related search

The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy

Przeglad Gastroenterologiczny
Gastroenterology
2018English

Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients With NSCLC

Materia Socio Medica
2016English

P2.01-112 Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio in Patients With Lung Cancer Treated With Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Value of Neutrophil‐to‐lymphocyte Ratio and Platelet‐to‐lymphocyte Ratio for Breast Cancer Patients: An Updated Meta‐analysis of 17079 Individuals

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Preoperative Platelet-To-Lymphocyte Ratio and Neutrophil-To-Lymphocyte Ratio as Predictors of Clinical Outcome in Patients With Gallbladder Cancer

Scientific Reports
Multidisciplinary
2019English

Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Neutrophil-Lymphocyte Ratio Complements Volumetric Staging as Prognostic Factor in Patients Treated With Definitive Radiotherapy for Oropharyngeal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Prognostic Role of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Bone Metastases

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy